MedPath

Predictive Factors for Medullary Thyroid Cancer Aggressiveness

Completed
Conditions
Medullary Thyroid Cancer
Registration Number
NCT06292988
Lead Sponsor
Aristotle University Of Thessaloniki
Brief Summary

This study is a retrospective study trying to find the predictive factors for medullary thyroid aggressiveness in terms of tumor metastasis and patients' survival.

Detailed Description

This study is a retrospective study trying to find the predictive factors for medullary thyroid aggressiveness in terms of tumor metastasis and patients' survival. The predictive factors included in this study are central and lateral compartment lymph node metastases as well as distant metastasis up to 1 year postoperatively, while biochemical predictors (meaning ratios such as lymphocyte to monocyte ratio etc and CEA and calcitonin drop levels) and histological predictors (such as nuclear atypia, amyloid, immunohistochemistry, desmoplasia) are included as secondary outcomes. In this study , patients \>18 years old that underwent surgery for medullary thyroid cancer (total thyroidectomy, completion thyroidectomy) +/- central/lateral neck dissection) will be enrolled.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
500
Inclusion Criteria
  • Patients who underwent thyroidectomy for medullary thyroid cancer (total thyroidectomy, completion thyroidectomy) +/- central/lateral neck dissection
Exclusion Criteria
  • Age < 18 years

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Central lymph node metastasisNumber of lymph node Metastasis found in preoperative imaging studies or up to 1 year postoperatively

Central neck compartment lymph node metastasis

Lateral lymph node metastasisNumber of lymph node Metastasis found in preoperative imaging studies or up to 1 year postoperatively

Lateral neck compartment lymph node metastasis

Distant metastasisNumber of distant Metastasis found in preoperative imaging studies or up to 1 year postoperatively

Liver and lung metastasis

Secondary Outcome Measures
NameTimeMethod
Nuclear atypia as histological predictor of aggressivenessThe pathology report is held immediately after surgery

nuclear atypia

White blood cell as Biochemical predictor of aggressivenesspre and postoperative laboratory exams up to 1 year postoperatively

white blood cell count

Amyloid as histological predictor of aggressivenessThe pathology report is held immediately after surgery

amyloid

CEA as Biochemical predictor of aggressivenesspre and postoperative laboratory exams up to 1 year postoperatively

Carcinoembryonic antigen (CEA) preoperatively and up to 1 year postoperatively

Immunohistochemistry as histological predictor of aggressivenessThe pathology report is held immediately after surgery

immunohistochemistry

Calcitonin as Biochemical predictor of aggressivenesspre and postoperative laboratory exams up to 1 year postoperatively

calcitonin levels preoperatively and up to 1 year postoperatively

CEA drop as Biochemical cure markerup to 1 year postoperatively

CEA drop levels

Calcitonin drop as Biochemical cure markerup to 1 year postoperatively

calcitonin drop levels

Desmoplasia as histological predictor of aggressivenessThe pathology report is held immediately after surgery

desmoplasia

Platelet count as Biochemical predictor of aggressivenesspre and postoperative laboratory exams up to 1 year postoperatively

platelet count

Trial Locations

Locations (46)

Oregon Health & Science University, Oregon

🇺🇸

Oregon City, Oregon, United States

Department of Surgery, Saint John of God Hospital, Salzburg, Austria

🇦🇹

Salzburg, Austria

Saint Luc, University Clouvain, Belgium

🇧🇪

Bruxelles, Belgium

Head and Neck Surgery Department, Hospital Ana Nery, Santa Cruz do Sul, Brazil

🇧🇷

Santa Cruz Do Sul, Brazil

University Clinic of Surgery, University Hospital "Lozenec"

🇧🇬

Sofia, Bulgaria

Chinese University of Hong Kong

🇨🇳

Hong Kong, China

Head and Neck Department Oncologos del Occidente, Universidad de Caldas, Manizales, Colombia

🇨🇴

Manizales, Colombia

the University Hospital Center Sestre milosrdnice, Zagreb, Croatia, Department of Otorhinolaryngology and Head and Neck Surgery

🇭🇷

Zagreb, Croatia

Head and Neck Surgery, Brest University Hospital, Brest, France

🇫🇷

Brest, France

The University Hospital of Poitiers, France

🇫🇷

Poitiers, France

Scroll for more (36 remaining)
Oregon Health & Science University, Oregon
🇺🇸Oregon City, Oregon, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.